OPGN יתרות המזומנים של החברה OpGen Corp

OpGen, Inc. (OPGN) focuses on monetizing diagnostic platforms and expanding Acuitas test sales following a financial restructuring. The current cash position demonstrates liquidity, with the latest value recorded as 0.00. The company's technologies accelerate the discovery of antibiotics to combat hospital-acquired infections. However, capital shortages and protracted disputes with European subsidiaries create significant risks to the business's survival.
פילוחי נתונים אנליטיים מרוכזים עבור OpGen Inc (OPGN)

When constructing a long-term portfolio, fundamental screening requires an assessment of liquidity relative to the asset's market value. This indicator compares net cash balances with market capitalization to identify the degree of undervaluation and bankruptcy risks. For OpGen, Inc. (OPGN), this is critical due to an acute shortage of funds and a management crisis. Analyzing the company's cash reserve volume on GURU.Markets allows for tracking management's ability to restructure its obligations.